Navigation Links
Global HIV Infection Drug Pipeline Analysis
Date:12/13/2013

MUMBAI, December 13, 2013 /PRNewswire/ --

Bharat Book Bureau presents Global HIV Infection Drug Pipeline Analysis. This report provides the discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retroviral in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have been successful in improving the quality of life for HIV patients and prevented the virus from developing into AIDS. The rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.6 in 2012, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and therapy in recent years.

     (Logo: http://photos.prnewswire.com/prnh/20130128/590935)

Bharat Book Bureau presents the report entitled "Global HIV Infection Drug Pipeline Analysis" (http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html ) It gives comprehensive insight on the various drugs being developed for the treatment of HIV Infection. Research report covers all the ongoing drugs being developed in various clinical development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process.

Following parameters for each drug profile in clinical development phase are covered in "Global HIV Infection Drug Pipeline Analysis" research report:

  • Drug Profile Overview
  • Alternate Names for Drug
  • Active Indication
  • Phase of Development
  • Mechanism of Action
  • Brand Name
  • Patent Information
  • Orphan Designation by Indication, Country & Organization
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • ATC Codes

HIV Infection Drug Development by Clinical Phase:

  • Research: 31
  • Preclinical: 140
  • Phase-I: 53
  • Phase-I/II: 18
  • Phase-II: 39
  • Phase-III: 7
  • Preregistration: 2
  • Registered: 2
  • Marketed: 34

Table of Contents

  • HIV Infection Drug Market Overview
  • HIV Infection Drug Clinical Development Phase: Research
  • Overview
  • HIV Infection Drug Profiles in Clinical Phases
  • HIV Infection Drug Clinical Development Phase: Preclinical
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-I
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-I/II
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-II
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-III
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Preregistration
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Registered
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • Marketed Drugs
  • Overview
  • Marketed Drug Profile

Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=430480

For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html

Related Reports:

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:

Poonam
Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Blog: http://blog.bharatbook.com
E: poonam@bharatbook.com
W: http://www.bharatbook.com

 


'/>"/>
SOURCE Bharat Book Bureau
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Equine Healthcare Market is Expected to Reach USD 24.5 Billion Globally in 2019: Transparency Market Research
2. CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
3. Global Radiation Detection, Monitoring & Safety Market Report 2013-2017
4. Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018
5. Wearable Medical Devices Market is Expected to Reach USD 5.8 Billion Globally in 2019: Transparency Market Research
6. Global Laparoscopic Devices Industry
7. Global Gelatin Industry
8. Global Carotenoids Industry
9. Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures
10. Intravenous Access Devices Market is Expected to Reach USD 46.5 Billion Globally in 2019: Transparency Market Research
11. EEG/EMG/Brain Function Monitoring - Global Strategic Business Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):